Search

everythinglearnresearchcommunity

for

Search:↓

Clinical signs don't match inflammation levels in lichen planopilaris and frontal fibrosing alopecia.

Finasteride boosts immune cells that suppress T-cells, possibly helping with immune disorders but may increase cancer risk.

Current alopecia treatments manage symptoms but don't cure, and better treatments are needed.

The conclusion is that Treg-targeted therapies have potential, but more knowledge of Treg biology is needed for effective treatments, including for cancer.

Treatments for permanent hair loss from scarring aim to stop further loss, not regrow hair, and vary by condition, with partial success common.

Resolving malaria-related lung issues doesn't rely on Alox12 and leaves some inflammation.

Osteopontin may play a role in alopecia areata, but its levels don't predict treatment success.

PRP therapy can temporarily grow hair in CCCA patients but isn't a permanent cure.

PRP or nanofat injections improve scar tissue quality but don't significantly boost hair transplant results for scarring hair loss.

External factors can cause skin cancer cells that usually don't spread to grow and form tumors in mice.

MILL molecules are unique immune proteins in mice that don't need TAP to appear on cell surfaces.

RSPO1 mutations in certain patients lead to skin cells that don't develop properly and are more likely to become invasive, increasing the risk of skin cancer.

Sentinel lymph node mapping is safe and effective for early-stage ovarian cancer but isn't yet standard practice.

Abnormal Hedgehog signaling in blood cancers may help tumors grow and resist chemotherapy, suggesting potential for targeted treatments.

FOXN1 gene mutations cause a rare, severe immune disease treatable with cell or tissue transplants.

Testosterone helps human pancreatic cells increase insulin release.

Excimer laser therapy can be an alternative for treating superficial morphea when topical steroids don't work.

Platelet-rich concentrates can be an alternative treatment for oral lichen planus, especially when steroids don't work.

Apple extract called procyanidin B-2 was found to greatly increase hair growth.

Early diagnosis and aggressive treatment are crucial for better outcomes in lymphomatoid granulomatosis.

Fish oil increased cell growth and macrophages in the skin but didn't affect COX-2 expression.

Topical PUVA can cause temporary hair regrowth in some alopecia areata patients but doesn't change the long-term outcome.

Teriflunomide is an effective and generally safe oral treatment for relapsing MS, reducing relapses and slowing disability progression.

Newborn screening and gene therapy are expected to improve outcomes for Omenn syndrome patients.

Astaxanthin may reduce inflammation in women with PCOS, but doesn't significantly improve symptoms.

A woman with unexplained hair loss was found to have harmless skin tumors and a scarring hair loss condition, but the tumors didn't cause the hair loss.

Natural products might help treat COVID-19, but current drugs like hydroxychloroquine haven't worked.

A woman thought to have rosacea was actually suffering from Frontal Fibrosing Alopecia, a hair loss condition. Despite treatment, her condition didn't change, showing the importance of accurate early diagnosis.

Innate lymphoid cells type 1 may contribute to alopecia areata by damaging hair follicles.

The document concludes that new treatments for skin conditions are complex but effective, including spironolactone for female hair loss and propranolol for infantile hemangiomas.